Immunoexpression of E-cadherin, β-catenin and Ezrin in non-small cell lung carcinomas

非小细胞肺癌中E-钙黏蛋白、β-连环蛋白和Ezrin的免疫表达

阅读:2

Abstract

Lung cancer continues to have the highest mortality rate in the world, non-small cell lung carcinoma (NSCLC) representing the most common tumor form. The therapeutic interference of the tumor intercellular adhesion disruption mechanisms can provide therapeutic targets to improve the patients' prognosis. The study included 52 cases diagnosed with NSCLC, for which the immunohistochemical expressions of E-cadherin, β-catenin and Ezrin were analyzed in relation to the epidemiological and histological prognostic parameters. The histopathological analysis indicated the predominance of high-grade acinar adenocarcinoma (ADK) and non-keratinizing squamous cell carcinoma (SCC), with frequent vascular invasion and in stages II-IV. Final staining scores (FSS) of E-cadherin were superior in the case of acinar, lepidic and papillary ADK, with a high degree of differentiation, without vascular invasion and in initial tumor stages. The same aspect was also observed in the case of β-catenin reactions, which were present only at the membrane level, increased FSS being also present in the case of mucinous carcinomas. The membrane/cytoplasmic immunoexpression of Ezrin was superior in the case of cribriform, solid, micropapillary, lepidic and non-keratinized squamous carcinomas, with vascular invasion and in advanced tumor stages. Membrane reactions of Ezrin prevailed only in the case of acinar, lepidic and papillary ADK. The negative linear correlation of E-cadherin and β-catenin with Ezrin and the relationships of the markers with the histological parameters of NSCLC indicate their utility potential for the identification of aggressive malignant lung tumors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。